Learn More     Subscribe    
Join Now!      Login
 
 
 
FREE HEALTH
NEWSLETTER
 
 
Ephedra Poll
Should the herb Ephedra be banned?
 
 
 
 
D
etection of Barbiturates in Urine
 

Detection of Barbiturates in Urine

© Toxicology Laboratories

Barbiturates have been known since 1864 when Dr. A. von Bayer synthesized barbituric acid. In 1903, barbital was introduced as a hypnotic for routine medicinal use. They were reclassified as Schedule 2 drugs in 1979 requiring a triplicate prescription to reduce the abuse of barbiturates. The benzodiazepines (Valium, Librium, Xanax) are generally safer in overdose and have largely replaced the use of barbiturates in medicinal pharmacology. Barbiturates are numerous, chemically derived from a common 2,4,6 trioxohexahydropyrimidine (barbituric acid) nucleus. Some of the common names are: phenobarbital (Luminol®), secobarbital (Seconal®), pentobarbital (Nembutal®), butalbital (Fiorinal®), amobarbital (Amytal®), and many others.

Pharmacological Effects
Barbiturates reversibly depress the activity of all excitable tissues. The use of phenobarbital in epilepsy, one of the few major remaining useful areas of barbiturate pharmacology, is due to its selective anticonvulsant activity depressing low frequency electrical activity in the cortex. Tolerance to barbiturates occurs with continued use. At first, a generalized sedative effect gives way to tolerance, especially toward effects on mood, sedation, and hypnosis. Like other central nervous system depressant drugs, barbiturates are abused and some individuals develop a dependence on them. Dependence upon and tolerance to barbiturates are closely related. The former, generating the drug seeking behavior that leads to increased usage and consequent higher levels of tolerance and hence the extent, duration, and continuity of abuse prior to withdrawal.

Laboratory Methods
Some labratories utilize immunoassay (EIA) for detecting barbiturates in urine. The immunoassays provide a cost effective, sensitive method for detection and reacts with a number of barbiturates. Gas chromatography/mass spectrometry (GC/MS) is used to further identify and confirm the presence of a particular barbiturate in the sample.

Cutoff and Detection Post Dose
The 200 ng/ml cutoff for the screening immunoassay allows detection of barbiturate use for up to 72 hours post dose. The cutoff level for GC/MS is 200 ng/ml for all barbiturate metabolites (amobarbital, butabarbital, butalbital, pentobarbital, phenobarbital, secobarbital). Various barbiturates have differing half lives of clearance post dose. For instance, the short acting barbiturate, secobarbital, has a half life of 29-34 hours, while phenobarbital, a long acting barbiturate, has a half life of 24-140 hours. Thus, use of phenobarbital may be detected much longer than secobarbital.

Add your comment      
About The Author
 
Share   Facebook   Buzz   Delicious   Digg   Twitter  
 
 
 
 
 
 
From Our Sponsor
 
 
 
 
 
 
Featured Events
Wellness Inventory Certification Training - Level I
     February 18-May 20, 2014
     Los Angeles, CA USA
 
Additional Calendar Links
 
Wellness, Communicating, dimension!

Search   
Home       Wellness       Health A-Z       Alternative Therapies       Find a Practitioner       Healthy Products       Bookstore       Wellness Inventory
Healthy Kitchen       Healthy Woman       Healthy Man       Healthy Child       Healthy Aging       Wellness Center       Nutrition Center       Fitness Center
Free Newsletter      What Doctor's Don't Tell You      Stevia.com      Discount Lab Tests      First Aid      Global Health Calendar      Privacy Policy     Contact Us

Disclaimer: The information provided on HealthWorld Online is for educational purposes only and IS NOT intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek professional medical advice from your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.